Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic

Risperdal Consta will be the first LONG-ACTING injectable ATYPICAL antipsychotic.

It can be given every 2 weeks in a clinic.

This could help patients who have trouble taking their meds...and possibly decrease the chance of hospitalization for relapse.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote